Immucell ICCC
NASDAQ ICCC
$10.58 +0.13 (+1.24%)
As of: Oct 21, 2026 · 12:58 PM EDT

Immucell (ICCC) EV to CFO (2012 - 2025)

Updated

Immucell's (ICCC) EV to CFO was 20.94 for Q4 2025, down 82.4% from 118.70 a year earlier and down 20.9% from the prior quarter.

Analysis

Immucell (ICCC) EV to CFO (2012 - 2025) Analysis & Trends

Dating back to Q2 2012, Immucell's EV to CFO record includes 42 quarters.

  • By year, EV to CFO came in at 118.70 in FY2024 and 54.24 in FY2021 (+103.8%).
  • The Q4 2025 figure ranks as the lowest quarterly EV to CFO since Q2 2020.
  • Per Business Quant data, the three quarters before Q4 2025 came in at 26.46 (Q3 2025), 22.49 (Q2 2025) and 25.39 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn
10 Immucell 95.91 Mn 73.35 Mn 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.94
Sep 30, 2025 26.46
Jun 30, 2025 22.49
Mar 31, 2025 25.39
Dec 31, 2024 118.70
Sep 30, 2022 143.69
Jun 30, 2022 30.27
Mar 31, 2022 28.38
Dec 31, 2021 54.24
Sep 30, 2021 118.59
Dec 31, 2020 26.61
Sep 30, 2020 29.89
Jun 30, 2020 15.13
Mar 31, 2020 49.15
Dec 31, 2019 121.50
Sep 30, 2019 215.84
Mar 31, 2019 464.27
Sep 30, 2018 452.63
Jun 30, 2018 100.69
Mar 31, 2018 207.49
API Access

Immucell EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ICCC&period=max&api_key=YOUR_API_KEY